
Cytovia Holdings, a biopharma company focused on natural killer (NK) cells, merged with special purpose acquisition company (SPAC) Isleworth Healthcare Acquisition Corp. to go public.
Cytovia Goes Public in SPAC Deal Amidst Slow Biotech IPO Environment
KULR-8 Local News